Skip to content

Surveillance Study of the Contraceptive Intrauterine Device UT380®

A Post Market Surveillance Study of the Performance and Safety of UT 380® Contraceptive Intra Uterine Device in Nulliparous, Uniparous and Multiparous Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03642171
Acronym
CCDDIUUT
Enrollment
200
Registered
2018-08-22
Start date
2018-07-26
Completion date
2024-09-23
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraceptive; Complications, Intrauterine

Keywords

Contraception, Intrauterine Device, UT380

Brief summary

The study is a long term Post Market Surveillance Study involving women who will received UT 380® device as a contraceptive method.

Detailed description

Prospective data on contraceptive performance of the UT380® from a large number of women are not yet available. Here we describe a long term Post Market Surveillance Study involving women who will received UT 380® device as a contraceptive method. Reports of case series usually contain detailed information about the individual patients. This includes demographic information (e.g. age and gender) and information on diagnosis, treatment, response to treatment, follow-up after treatment and patients experience of the treatment. In addition, it also include the health care staff's experience of the use of the UT 380. The result of this study will be used for different purposes e.g. marketing activities such as posters, folders, or targeted journals and/or conferences.

Interventions

None listed

Sponsors

Prodimed S.A.
CollaboratorOTHER
CCD
CollaboratorUNKNOWN
Quanta Medical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman \> 18 years old * nulliparous, uniparous and multiparous * not currently using a contraceptive method or are willing to switch to a new reversible contraceptive * with an indication of implantation of a UT380® IUD * agreeing to participate in the study

Exclusion criteria

* Patient with risk of post implantation bleeding or high level of bleeding during menstruation period * Patient with a risk of infection * Patient that meet any of the absolute contraindication of UT 380® * Any other elements that the investigator may think relevant and cannot allow the use of UT380®

Design outcomes

Primary

MeasureTime frameDescription
Unintended pregnancy rate5 yearsUnintended pregnancy rate
Device expulsion rate5 yearsDevice expulsion rate
Discontinuation rate5 yearsDiscontinuation rate

Secondary

MeasureTime frameDescription
Removal rate of the UT380® due to excessive bleeding5 years
Removal rate of the UT380® due to pain5 years
Removal rate of the UT380® due to pelvic inflammatory diseases5 years
Removal rate of the UT380® due to other disease relevant in the contexte of the trial5 years
Removal rate of the UT380® due to desired pregnancy5 years
Extra uterine pregnancy rate5 yearsExtra uterine pregnancy rate
Removal rate of the UT380® due to investigator decision5 years
Safety data such as uterin perforation5 yearsUterin perforation rate
Safety data such as any issue occurring immediately after the implantation of the device5 yearsRate of issue occurring immediately after the implantation of the device
Safety data such as any issue occurring between two visits: Abdominopelvic or uterine pain outside the menstrual cycle, bleeding,5 yearsRate of issue occurring between two visits
Safety data such as any issue during the device removal (such as pain, breaking device, excessive pulling force…)5 yearsRate of issue during the device removal
Removal rate of the UT380® due to any other personal reason5 years
Assessment of physicians satisfaction regarding the use of the UT380 using 5 points likert scale (1: not at all satisfied 5: very satisfied)5 yearsPhysicians satisfaction regarding the use of the UT 380 will be assessed at post implantation visit (2 visits the fisrt year, and one visit per years during the following 4 years) using 5 points likert scale (1: not at all satisfied 5: very satisfied)
Assessment of patients satisfaction regarding the use of the UT 380® using 5 points likert scale (1: not at all satisfied 5: very satisfied)5 yearsPatients satisfaction regarding the use of the UT 380® will be assessed at post implantation visit (2 visits the fisrt year, and one visit per years during the following 4 years) using 5 points likert scale (1: not at all satisfied 5: very satisfied)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026